|
Legaz I, Muro M. Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes. Int J Mol Sci. 2023 Apr 24;24(9):7743. doi: 10.3390/ijms24097743. PubMed PMID: 37175450; PubMed Central PMCID: PMC10178591.
AÑO: 2023; IF: 4.9
|
37175450
|
Legaz I, Morales R, Bolarin JM, Collados-Ros A, Pons JA, Muro M. Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles? Biomedicines. 2023 Aug 28;11(9):2405. doi: 10.3390/biomedicines11092405. PubMed PMID: 37760846; PubMed Central PMCID: PMC10525207.
AÑO: 2023; IF: 3.9
|
|
Alfaro R, Llorente S, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, de la Pena-Moral J, Minguela A, Legaz I, Muro M. Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients. Transplant Proc. 2023 Jan-Feb;55(1):66-71. doi: 10.1016/j.transproceed.2022.12.012. Epub 2023 Jan 6. PubMed PMID: 36621349.
AÑO: 2023; IF: 0.8
|
|
Moya-Quiles MR, Muro M. Identification of a novel HLA-DPA1 allele, HLA-DPA1*02:102Q. HLA. 2023 Oct;102(4):546-548. doi: 10.1111/tan.15140. Epub 2023 Jun 24. PubMed PMID: 37354083.
AÑO: 2023; IF: 5.9
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 May;25(5):1446-1454. doi: 10.1007/s12094-022-03042-z. Epub 2023 Jan 4. PubMed PMID: 36598635.
AÑO: 2023; IF: 2.8
|